Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR<sup>+</sup> Acute Lymphoblastic Leukemia.

Cancers (Basel) · 2023 · PMC10486903 · PMID 37686604

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In clone 2, a decreasing trend of SMAD2/3 phosphorylation by dasatinib was observed when a high amount of TGF-β1 was used ( Figure 2 ). 3.3.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.